All Resources

Private Drug Coverage • November 25, 2022

Cost Drivers: Analysis of Private Drug Plans in Canada 2022

Learn more|View

Access to Medicine • November 17, 2022

Innovative Agreements Framework

Learn more|View

Economic Impact • October 07, 2022

Pre-Budget Consultations in Advance of the 2023 Budget

Learn more|View

Access to Medicine • July 06, 2022

Developing a Pan-Canadian Genomics Strategy: Innovative Medicines Canada Response

Learn more|View

Access to Medicine • February 12, 2022

Optimizing Patient Access to Precision Therapies: Preparing for the Emerging Era of Advanced Testing

Learn more|View

Access to Medicine • February 05, 2022

Bluesky Project

Reimagining Canada’s Approval and Reimbursement System for Innovative Medicines February 2022…

Learn more|View

January 14, 2022

2022 Ontario Pre-Budget Consultation

Learn more|View

Private Drug Coverage • August 01, 2021

Cost Drivers: Analysis of Private Drug Plans in Canada 2021

Learn more|View

Economic Impact • May 30, 2021

The Canadian Research and Development Pharmaceutical Sector

Learn more|View

Vaccine Equity • April 30, 2021

Standing Committee on International Trade (CIIT) study of Canada’s International Trade and Investment Policy

Learn more|View

Drugs for Rare Diseases (DRD) • March 26, 2021

Towards a Value-based and Pan-Canadian Rare Disease Strategy

Learn more|View

Access to Medicine • August 20, 2020

IMC and BTC joint response to CADTH’s transparency consultation

Learn more|View